Kanefron N in the treatment of non-diabetic glucosuria in patients with recurrent upper urinary tract infection


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. Purpose to analyze the effectiveness of the herbal preparation Canephron N in the relief of nondiabetic glucosuria in patients with recurrent upper urinary tract infection (UTI). Materials and methods: the study included 100 patients, 53 of them were women (median age of all patients 42 (35; 58) years) with recurrent UTI. Patients were referred to the urology department to exclude the obstructive component and concomitant chronic diseases. Upon further examination, all patients were found to have nondiabetic glucosuria. Fifty patients received standard etiotropic treatment, in 25 patients it was simultaneously supplemented with the herbal drug Canephron N, and 25 patients, after standard treatment, continued monotherapy with this phytopreparation. Clinical and laboratory dynamics was assessed in the course of various treatment regimens. Results. The study found that the recurrent course of chronic UTI may be associated with nondiabetic glucosuria. In patients who received standard therapy in combination with the herbal preparation Kanephron N, a decrease in the intensity of nondiabetic glucosuria with more effective eradication of the bacterial pathogen was noted. At the same time, monotherapy of manifestations of IVMP, which are refractory to etiotropic therapy, with Kanefron N also proved to be quite effective. Conclusion: the combination of standard therapy for refractory manifestations of UTI with the herbal preparation Kanephron N is accompanied by the leveling of nondiabetic glucosuria (1.3+0.4 and 0.6+0.4 mmol/L, p<0.05), coinciding with a decrease in leukocyturia (25.5+4.5 and 9.5+1.5 in field of vision, p<0.05)

Full Text

Restricted Access

About the authors

B. A Berdichevsky

Tyumen State Medical University of the Ministry of Health of Russia

Email: doktor_bba@mail.ru
Ph.D., MD, professor, professor at the Department of Oncology with a course of Urology

V. B Berdichevsky

Tyumen State Medical University of the Ministry of Health of Russia

Ph.D., MD, associate professor at the Department of Oncology with a course of Urology

V. A Shidin

Tyumen State Medical University of the Ministry of Health of Russia

Ph.D., associate professor at the Department ofHistology

A. A Cologne

Tyumen State Medical University of the Ministry of Health of Russia

Ph.D., assistant at the Department of Oncology with a course of Urology

A. A Naletov

Tyumen State Medical University of the Ministry of Health of Russia

assistant at the Department of Oncology with a course of Urology

S. V Khilkevich

«Regional Clinical Hospital No. 2», Tyumen

head of Department of Urology

V. G Novoselov

Medical hospital "Oilman"

Head of the Department of Urology

References

  1. Урология. Российские клинические рекомендации под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря. М.: ГЭОТАР-Медиа, 2016. 496 с.
  2. Зайцев A.B., Ширяев A.A., Ким Ю.А. и соавт. Инфекции мочевыводящих путей. Современная тактика врача-уролога. РМЖ. 2019; 11:21-26
  3. Dason S., Dason J.T., Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5(5):316-322. doi: 10.5489/cuaj.ll214.
  4. Fauci A.S., Marston I.D. The Perpetual Challenge of Antimicrobial Resistance. JAMA. 2014;311(18):1853 1854; doi: 10.1001/jama.2014.2465.
  5. Fitzpatrick M.C., Bauch C.T., Townsend J.P., Galvani A.P. Modelling microbial infection to address global health challenges. Nat Microbiol. 2019;4( 10):1612-1619. doi: 10.1038/s41564-019-0565-8.
  6. Sullivan M.J., Ulett G.C. Evaluation of hematogenous spread and ascending infection in the pathogenesis of acute pyelonephritis due to group В. streptococcus in mice. Microb Pathog. 2020;138:103796. Doi: 10.1016/j. micpath.2019.103796.
  7. Heesterbeek H. et al. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015;347(6227):aaa4339.
  8. Ducarmon QR, Zwittink RD, Homung BVH, et al. Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection. Microbiol Mol Biol Rev. 2019;83(3):e00007-19. doi: 10.1128/MMBR.00007-19.
  9. Sommer F., Backhed F. The gut microbiota - masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227-238. Doi:10.1038/ nrmicro2974.
  10. Beerepoot M.A., Geerlings S.E., van Haarst E.P. et al. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190(6):1981-9. doi: 10.1016/j.juro.2013.04.142.
  11. Sender R., Fuchs S., Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016 Aug 19;14(8):e1002533. doi: 10.1371/journal.pbio.1002533.
  12. Kuldeep Dhama, Ruchi Tiwari, Sandip Chakraborty et al. Evidence Based Antibacterial Potentials of Medicinal Plants and Herbs Countering Bacterial Pathogens Especially in the Era of Emerging Drug Resistance: An Integrated Update. International Journal of Pharmacology. 2014;10:1-43.
  13. Hung CC, Lin HY, Lee JJ, et al. Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic Kidney Disease. Sci Rep. 2016;6:39372. doi: 10.1038/srep39372.
  14. Мартынюк Л.П., Мартынюк Лар П., Ружицкая О.А., и соавт. Влияние растительного препарата Канефрон® H. на течение диабетической нефропатии у пациентов с сахарным диабетом 2-го типа: результаты сравнительного когортного исследования. Почки 2015;1(11):24-32.
  15. Hung C.C., Lin H.Y., Lee J.J. et al. Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic KidneyDisease. Scientific Reports. 2016;6:39372. doi: 10.1038/srep39372.
  16. Перепанова Т.С. Федеральные клинические рекомендации «Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов - 2015 г.». Терапевтический архив. 2016;88(4):100- 104). https://doi.org/10.17116/terarkh2016884100-104
  17. Набер К.Г., Перепанова Т.С. Обзор эффективности и безопасности препарата Канефрон® Н. при лечении и профилактике урогенитальных и гестационных заболеваний. Российский медицинский журнал. 2012;18:4:922-927
  18. Набер К.Г., Алиджанов Ж.Ф. Существуют ли альтернативные методы антибактериальной терапии и профилактики неосложненных инфекций мочевыводящих путей? Урология. 2016;3(Спецвыпуск):37-44
  19. Шилов Е.М. Нефрология. Клинические рекомендации под ред. Е.М. Шилова, А.В. Смирнова, Н.Л. Козловской. М.: ГЭОТАР-Медиа, 2016. 816 с. ISBN 978-5-9704-3714-8.
  20. Morris J.A., Harrison L.M., Biswas J., et al. Transient bacteraemia: A possible cause of sudden life threatening events. Medical Hypotheses. 2007;69:1032- 1039. Share Cite https://doi.org/10.1016Zj.mehy.2007.02.039
  21. Berdichevskyy B.A., Berdichevskyy V.B. Non-diabetic glucosuria as one of the possible factors of formation of chronic kidney disease. Global Journal of Urology and Nephrology. 2020;3:21. doi: 10.28933/gjun-2020-02-1305.
  22. Stefkov G., Miova B., Dinevska-Kjovkarovska S., et al. Chemical characterization of Centaurium erythrea L. and its effects on carbohydrate and lipid metabolism in experimental diabetes. J. Ethnopharmacol. 2014;152(1):71-77.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies